ACT Brief FDA CRL Transparency Pause Protocol-Centric Recruitment Model Shift and Medical Affairs Integration

1 news trends Newsylist has tracked involving ACT Brief FDA CRL Transparency Pause Protocol-Centric Recruitment Model Shift and Medical Affairs Integration — newest first.

▲ Peaking Business 🔮 holds

FDA releases 14 drug rejection letters after 3-month pause

The FDA has resumed the release of pharma rejection letters, issuing 14 Complete Response Letters (CRLs) following a three-month disclosure freeze.

5 sources 5 articles v 3 2h ago